Clinical trial
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
NCT04431141
Study timeline
Study start (actual)2020-09-15Date precision: day
Registry last updated2021-11-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
TeneligliptinDRUG
EmpagliflozinDRUG · verified · RxNorm: empagliflozin
Sponsors & collaborators
Handok Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04431141 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.